From *Research Group of Assessment in Drug Vigilance and Supplementation in Exercise (ADViSE), Department of Health Science, European University Miguel de Cervantes, Valladolid, Spain
the †Department of Nutrition and Dietetic, Hospital Recoletas Campo Grande, Valladolid, Spain
‡School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
the §Neonatal Intensive Care Unit, Fondazione IRCCS Ca‘ Granda Ospedale Maggiore Policlinico, Milan, Italy
the ‖Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
¶UCLouvain, Cliniques Universitaires St Luc Pediatric GI & Hepatology, Brussels, Belgium
#Hebrew University, Jerusalem, Israel.
Received September 8, 2022; accepted December 5, 2022.
The authors report no conflicts of interest.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (www.jpgn.org).
Disclaimer: Although this paper is produced by the ESPGHAN Ethical Committee it does not necessarily represent ESPGHAN policy and is not endorsed by ESPGHAN.
Address correspondence and reprint requests to Paula Crespo-Escobar, PhD, Department of Health Science, European University Miguel de Cervantes C. del Padre Julio Chevalier, 2, 47012 Valladolid, Spain (e-mail: [email protected]).
